Read more about Benchmarks trade lower; breadth remains positive on Business Standard. The domestic equity indices continued trading with modest losses in afternoon trade. The Nifty hovered above 14,750 mark.
Uniindia: Mumbai, May 12 (UNI) Zydus Animal Health and Investments Limited (ZAHL), a wholly owned material subsidiary of Cadila Healthcare Limited, has entered into a Business Transfer Agreement (BTA) and other Ancillary Agreements (Definitive Agreements) to sell and transfer its Animal Healthcare Established Markets Undertaking to Multiples Alternate Asset Management led consortium.
Equity platform Multiples-led consortium buys Zydus Animal Health biz for Rs 2921 Cr
Equity platform Multiples-led consortium buys Zydus Animal Health biz for Rs 2921 Cr
12 May 2021 | News Multiples, along with its consortium partners, will acquire 100% business of Zydus AH through a slump sale transaction
Image credit- shutterstock.com
Private equity platform Multiples Alternate Asset Management (Multiples) led consortium, through an SPV controlled by them, have signed a Business Transfer Agreement (BTA) and other Ancillary Agreements to acquire Animal Healthcare Established Markets Undertaking (Zydus AH).
The consortium including Multiples, Canada Pension Plan Investment Board (CPP Investments) and RARE Enterprises, is buying the animal health business of Zydus AH focused on India and certain other countries on a going concern basis via a slump sale from Zydus Animal Health and Investments Limited (ZAHL), a wholly owned subsidiary of Cadila Healthcare.
Nifty, Sensex under remains under pressure from global factors – Wednesday closing report
Moneylife Digital Team
0
We had mentioned in Tuesday’s closing report that Nifty, Sensex may move sideways. On Wednesday, the indices opened higher but ended in the red with minor losses. On the NSE, there were 887 advances, 1,088 declines and 61 unchanged.
The trends of the major indices in the course of Wednesday’s trading are given in the table below:
Cadila Healthcare has informed the exchanges that a consortium of investors Multiples Alternate Asset Management, Canada Pension Plan Investment Board (CPPIB) and Rakesh Jhunjhunwala-backed Rare Enterprises will buy its animal healthcare business for Rs 2,921 crore.